Literature DB >> 15173772

The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging.

Mark I Travin1, Gary V Heller, Lynne L Johnson, Deborah Katten, Alan W Ahlberg, Carmen R Isasi, Robert C Kaplan, Cynthia C Taub, Diane Demus.   

Abstract

BACKGROUND: The ability of stress radionuclide myocardial perfusion imaging to predict adverse cardiac events is well accepted. As left ventricular systolic function has also been shown to be an important prognostic indicator, the objective of this study was to determine whether electrocardiography (ECG)-gated single photon emission computed tomography (SPECT) functional data add additional power. METHODS AND
RESULTS: In this study 3207 patients who underwent stress myocardial perfusion imaging with ECG gating, without early (</=60 days) revascularization, were studied. Subsequent nonfatal myocardial infarction and cardiac death were related to perfusion and ECG-gated SPECT ventricular function parameters. Cox proportional hazards regression analysis was used to evaluate the independent predictive value of these parameters, as well as their added utility over clinical and ECG parameters. Patients with abnormal perfusion images had an annual event rate of 5.1% compared with 1.6% for patients with normal images (P <.001). An abnormal gated SPECT wall motion score was associated with an annual event rate of 6.1% compared with 1.6% for a normal score (P <.001), and an abnormal left ventricular ejection fraction was associated with an event rate of 7.4% compared with 1.8% for normal patients (P <.001). Abnormal ECG-gated SPECT results worsened outcome in both patients with normal perfusion images and those with abnormal perfusion images. Cardiac death was predicted by the number of territories with a perfusion defect and an abnormal ejection fraction, whereas myocardial infarction was predicted by the number of territories with a perfusion defect but not by ejection fraction.
CONCLUSIONS: Ventricular function data from ECG-gated SPECT add important prognostic value to data obtained from perfusion imaging alone in predicting adverse cardiac events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173772     DOI: 10.1016/j.nuclcard.2004.02.005

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  35 in total

Review 1.  Recent advances in myocardial perfusion imaging.

Authors:  D S Berman; S W Hayes; L J Shaw; G Germano
Journal:  Curr Probl Cardiol       Date:  2001-01       Impact factor: 5.200

Review 2.  Dobutamine stress myocardial perfusion imaging in coronary artery disease.

Authors:  Abdou Elhendy; Jeroen J Bax; Don Poldermans
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

Review 3.  Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.

Authors:  Charanjit S Rihal; Dominic L Raco; Bernard J Gersh; Salim Yusuf
Journal:  Circulation       Date:  2003-11-18       Impact factor: 29.690

Review 4.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

5.  Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi.

Authors:  N Nallamouthu; L Araujo; J Russell; J Heo; A E Iskandrian
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

6.  Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population.

Authors:  D A Calnon; P D McGrath; A L Doss; F E Harrell; D D Watson; G A Beller
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

7.  Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction.

Authors:  T Sharir; G Germano; X Kang; H C Lewin; R Miranda; I Cohen; R D Agafitei; J D Friedman; D S Berman
Journal:  J Nucl Med       Date:  2001-06       Impact factor: 10.057

8.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

9.  Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; C N Bairey; I Cohen; A Cabico; J Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

10.  Prognostic value of combined assessment of regional left ventricular function and myocardial perfusion by dobutamine and rest gated SPECT in patients with uncomplicated acute myocardial infarction.

Authors:  Letizia Spinelli; Mario Petretta; Wanda Acampa; Wei He; Andrea Petretta; Domenico Bonaduce; Alberto Cuocolo
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

View more
  36 in total

1.  Ischemic changes on rubidium-82 positron emission tomography imaging are associated with left ventricular functional and volumetric change independent of metabolic properties and echocardiographic functional variables in ischemic cardiomyopathy.

Authors:  Raymond C Wong; Manuel D Cerqueira; Richard C Brunken
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-11       Impact factor: 2.357

2.  In retroSPECT: the prognostic value of nuclear cardiology-past, present, and future.

Authors:  Dorinna D Mendoza; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

3.  Quantitative single-photon emission computed tomography imaging.

Authors:  Guido Germano; Daniel S Berman
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

4.  Role of regional myocardial dysfunction by gated myocardial perfusion SPECT in the prognostic evaluation of patients with coronary artery disease.

Authors:  Tali Sharir
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

5.  The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

6.  Revascularize only for ischemia, especially if left ventricular function is poor.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 7.  Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 8.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

9.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

10.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.